Cabaletta Bio, Inc.
corporate_fare Company Profile
Cabaletta Bio, Inc. (NASDAQ:CABA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for CABA at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Cabaletta Bio Reports Substantial Doubt About Going Concern, Increased Losses, and Details of Recent Capital Raises Amidst Clinical Progress
- Cabaletta Bio Reports Q4/FY2025 Results, Secures $30M, Advances Lead CAR T Program Towards 2027 BLA
- Cabaletta Bio Targets 2027 Myositis BLA, Details Key Clinical Milestones & 1H26 Data
- Cabaletta Bio Initiates Pivotal Myositis Trial, Secures FDA Alignment for Lupus, and Advances Automated Manufacturing for rese-cel
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$167.86M
Diluted EPS
-$2.10
Op. Cash Flow
-$131.08M
Free Cash Flow
-$132.31M
Operating Income
-$172.24M
Cash & Equivalents
$82.98M
Debt / Equity
0.00×
Shares Outstanding
100.48M sh
Source: 10-K · filed 2026-03-23 · accession 0001759138-26-000011
show_chartPrice Chart
Loading chart...
feed CABA - Filings & News (Page 2)
CABA
Mar 23, 2026, 7:36 AM EDT
Price at Filing:
$2.99
Real-time Price:
$0.9699
Change:
-$2.02 (-68%)
Market Cap:
$201.936M
CABA
Mar 23, 2026, 7:32 AM EDT
Price at Filing:
$2.99
Real-time Price:
$0.9699
Change:
-$2.02 (-68%)
Market Cap:
$201.936M
CABA
Mar 23, 2026, 7:30 AM EDT
Price at Filing:
$2.99
Real-time Price:
$0.9699
Change:
-$2.02 (-68%)
Market Cap:
$201.936M
CABA
Jan 12, 2026, 8:02 AM EST
Price at Filing:
$2.10
Real-time Price:
$0.9699
Change:
-$1.13 (-54%)
Market Cap:
$201.936M